Summary

Snap-8 (acetyl octapeptide-3) is an elongated analogue of Argireline developed by Lipotec for cosmetic anti-ageing research. By extending the hexapeptide sequence to eight amino acids, it more closely mimics SNAP-25, potentially offering greater potency in reducing expression-line wrinkles through neurotransmitter release inhibition. Evidence is primarily from manufacturer data and small clinical studies. For research and educational purposes only.

Mechanism

Snap-8 (acetyl octapeptide-3) is an elongated analogue of Argireline, designed to more closely mimic the N-terminal region of SNAP-25. Like Argireline, it inhibits SNARE complex assembly, reducing neurotransmitter release at the neuromuscular junction. The additional two amino acids extend the SNAP-25 mimicry region, potentially improving binding affinity and potency. The result is partial attenuation of muscle contraction, reducing expression-line formation.

Evidence base

Evidence Grade: Limited. Key findings: SNARE complex inhibition with extended sequence; manufacturer data claims approximately 30% greater potency than Argireline in vitro (not independently verified); small clinical study (n=17) reported up to 63% wrinkle depth reduction at 28 days with 10% formulation (industry-funded, not replicated). Limitations: Very few peer-reviewed studies; most data from manufacturer technical sheets. Clinical studies are small and industry-funded.

Protocols

Snap-8 is formulated topically at 5 to 10% concentration in cosmetic preparations, applied once or twice daily to expression-line areas. Effects observed over 2 to 4 weeks; reversible upon discontinuation. Not administered by injection. Not medical advice.

Snap-8 is a cosmetic ingredient, not a licensed medicine. It is legal to purchase, possess, and use in cosmetic formulations in the UK. It is regulated under UK cosmetic regulations (Cosmetic Products Enforcement Regulations 2013) rather than MHRA pharmaceutical regulations.

Vendor notes

Snap-8 is available from cosmetic ingredient suppliers. For research-grade material, look for suppliers providing certificates of analysis confirming peptide identity and purity (at least 98%).

References

  1. Blanes-Mira C, et al. A synthetic hexapeptide (Argireline) with antiwrinkle activity. International Journal of Cosmetic Science. 2002. DOI: 10.1046/j.1467-2494.2002.00110.x
  2. Schagen SK. Topical peptide treatments with effective anti-aging results. Cosmetics. 2017. DOI: 10.3390/cosmetics4020016
  3. Lipotec and Lubrizol. Snap-8 technical data sheet. Industry data, not independently peer-reviewed.
  4. Gorouhi F, Maibach HI. Role of topical peptides in preventing or repairing aged skin. International Journal of Cosmetic Science. 2009. DOI: 10.1111/j.1468-2494.2009.00490.x